Today's Daily Dose brings you news about MabVax' stock offering; Caladrius Q1 results; ImmunoCellular's uncertainty surrounding its financial resources; Sophiris' upcoming catalyst; Akebia's license agreement related to Vadadustat; Ionis' phase III study results of Inotersen and Pernix' liquidity position.
from RTT - Biotech http://ift.tt/2qqo2H9
via IFTTT
No comments:
Post a Comment